Aims Despite widely available risk stratification tools, safe and effective anticoagulant
options, and guideline recommendations, anticoagulation for stroke prevention in atrial …

Background Many patients with atrial fibrillation (AF) do not receive oral anticoagulants
(OAC) for the prevention of stroke and systemic embolism. We aimed to improve the …

Background Atrial fibrillation (AF) is associated with substantial morbidity, in particular
stroke. Despite good evidence for the reduction of stroke risk with anticoagulant therapy …

Background Atrial fibrillation (AF) is associated with substantial morbidity, in particular
stroke. Despite good evidence for the reduction of stroke risk with anticoagulant therapy …

Background Clinical guidelines recommend anticoagulation for patients with atrial fibrillation
(AF) at high risk of stroke; however, studies report 40% of this population is not …

Background Guidelines on atrial fibrillation (AF) recommend the CHA 2 DS 2-VASc rule for
anticoagulant decision-making, but underuse exists. We studied the impact of an automated …

Background Atrial fibrillation is associated with stroke, yet approximately 50% of patients are
not treated with guideline-directed oral anticoagulants (OACs). Aims Given that the etiology …

Background: The decision-making process for stroke prevention in atrial fibrillation (AF)
requires a comprehensive assessment of risk vs. benefit and an appropriate selection of …

Background Appropriate thromboprophylaxis for patients with atrial fibrillation (AF) remains
a national challenge. Methods We hypothesized that provision of decision support in the …

Background Oral anticoagulation is recommended for stroke prevention in intermediate/high
stroke risk atrial fibrillation (AF) patients. The objective of this study was to demonstrate the …